4-IBP

CAS No. 155798-08-6

4-IBP( —— )

Catalog No. M18082 CAS No. 155798-08-6

4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 37 In Stock
5MG 58 In Stock
10MG 83 In Stock
25MG 176 In Stock
50MG 344 In Stock
100MG 511 In Stock
200MG 734 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-IBP
  • Note
    Research use only, not for human use.
  • Brief Description
    4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .
  • Description
    4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    σ1|σ2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    155798-08-6
  • Formula Weight
    420.29
  • Molecular Formula
    C19H21IN2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 20 mg/mL 47.59 mM;H2O : < 0.1 mg/mL
  • SMILES
    Ic1ccc(cc1)C(=O)NC3CCN(Cc2ccccc2)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sumaresinolic Acid

    Sumaresinolic Acid is a chemical compound.

  • Tryptamine hydrochlo...

    Tryptamine hydrochloride is a useful organic compound for research related to life sciences.

  • Ladanein

    Ladanein is a phytochemicals inhibitor that is known to disrupt the interactions of core and other hepatitis C virus (HCV) proteins.Ladanein possesses free radicals DPPH and ABTS +.scavenging activity, it also displays moderate (20-40 microM) activities against K562, K562R (imatinib-resistant), and 697 human leukemia cell lines.